Eclectic Associates Inc. ADV raised its position in UnitedHealth Group Incorporated (NYSE:UNH – Get Rating) by 0.3% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 10,184 shares of the healthcare conglomerate’s stock after purchasing an additional 29 shares during the period. UnitedHealth Group accounts for 2.5% of Eclectic Associates Inc. ADV’s investment portfolio, making the stock its 8th biggest position. Eclectic Associates Inc. ADV’s holdings in UnitedHealth Group were worth $4,813,000 at the end of the most recent quarter.
Other large investors have also recently bought and sold shares of the company. Moneta Group Investment Advisors LLC lifted its holdings in shares of UnitedHealth Group by 100,076.4% during the 4th quarter. Moneta Group Investment Advisors LLC now owns 11,823,820 shares of the healthcare conglomerate’s stock worth $6,268,753,000 after acquiring an additional 11,812,017 shares during the last quarter. Norges Bank bought a new stake in shares of UnitedHealth Group during the 4th quarter worth $5,210,004,000. Arrowstreet Capital Limited Partnership lifted its holdings in shares of UnitedHealth Group by 1,682.4% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 2,691,542 shares of the healthcare conglomerate’s stock worth $1,372,606,000 after acquiring an additional 2,540,538 shares during the last quarter. Morgan Stanley lifted its stake in UnitedHealth Group by 13.8% in the fourth quarter. Morgan Stanley now owns 15,635,038 shares of the healthcare conglomerate’s stock worth $8,289,386,000 after purchasing an additional 1,893,192 shares during the last quarter. Finally, Vanguard Group Inc. lifted its stake in UnitedHealth Group by 1.0% in the third quarter. Vanguard Group Inc. now owns 82,969,869 shares of the healthcare conglomerate’s stock worth $41,903,103,000 after purchasing an additional 851,994 shares during the last quarter. 92.61% of the stock is owned by institutional investors.
Insider Transactions at UnitedHealth Group
In other news, EVP Erin Mcsweeney sold 1,008 shares of the company’s stock in a transaction that occurred on Friday, April 21st. The shares were sold at an average price of $484.58, for a total value of $488,456.64. Following the transaction, the executive vice president now owns 10,359 shares in the company, valued at $5,019,764.22. The sale was disclosed in a legal filing with the SEC, which is available at this link. In related news, EVP Erin Mcsweeney sold 1,008 shares of the stock in a transaction that occurred on Friday, April 21st. The shares were sold at an average price of $484.58, for a total transaction of $488,456.64. Following the transaction, the executive vice president now owns 10,359 shares in the company, valued at $5,019,764.22. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, CEO Andrew Witty sold 6,160 shares of the stock in a transaction that occurred on Thursday, April 27th. The shares were sold at an average price of $487.49, for a total transaction of $3,002,938.40. Following the transaction, the chief executive officer now owns 86,564 shares in the company, valued at approximately $42,199,084.36. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 8,852 shares of company stock worth $4,313,962. Corporate insiders own 0.35% of the company’s stock.
Wall Street Analysts Forecast Growth
UnitedHealth Group Price Performance
Shares of UNH opened at $458.49 on Tuesday. The stock has a market cap of $426.87 billion, a PE ratio of 20.96, a price-to-earnings-growth ratio of 1.34 and a beta of 0.68. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.81 and a current ratio of 0.81. UnitedHealth Group Incorporated has a fifty-two week low of $445.68 and a fifty-two week high of $558.10. The firm’s 50-day simple moving average is $488.74 and its two-hundred day simple moving average is $493.72.
UnitedHealth Group (NYSE:UNH – Get Rating) last announced its quarterly earnings data on Friday, April 14th. The healthcare conglomerate reported $6.26 earnings per share for the quarter, topping analysts’ consensus estimates of $6.24 by $0.02. The business had revenue of $91.93 billion for the quarter, compared to analysts’ expectations of $89.77 billion. UnitedHealth Group had a net margin of 6.16% and a return on equity of 27.05%. The business’s revenue was up 14.7% compared to the same quarter last year. During the same quarter in the prior year, the company earned $5.49 earnings per share. Analysts anticipate that UnitedHealth Group Incorporated will post 24.86 earnings per share for the current fiscal year.
UnitedHealth Group Increases Dividend
The company also recently announced a quarterly dividend, which will be paid on Tuesday, June 27th. Stockholders of record on Monday, June 19th will be paid a $1.88 dividend. This represents a $7.52 annualized dividend and a dividend yield of 1.64%. The ex-dividend date of this dividend is Thursday, June 15th. This is an increase from UnitedHealth Group’s previous quarterly dividend of $1.65. UnitedHealth Group’s dividend payout ratio is currently 34.39%.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Read More
- Get a free copy of the StockNews.com research report on UnitedHealth Group (UNH)
- Trading Stocks: RSI and Why it’s Useful
- Why Mosaic’s Price Targets May Be Understated
- Amazon And The AI War: iRobot Acquisition In Focus
- What Does Logitech CEO’s Abrupt Departure Mean?
- Ulta Beauty Stock Value is More Than Skin Deep
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.
